{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T19:49:57Z","timestamp":1794253797135,"version":"4.9.0"},"reference-count":191,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T00:00:00Z","timestamp":1620086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Hepatic fibrosis is a dynamic process that occurs as a wound healing response against liver injury. During fibrosis, crosstalk between parenchymal and non-parenchymal cells, activation of different immune cells and signaling pathways, as well as a release of several inflammatory mediators take place, resulting in inflammation. Excessive inflammation drives hepatic stellate cell (HSC) activation, which then encounters various morphological and functional changes before transforming into proliferative and extracellular matrix (ECM)-producing myofibroblasts. Finally, enormous ECM accumulation interferes with hepatic function and leads to liver failure. To overcome this condition, several therapeutic approaches have been developed to inhibit inflammatory responses, HSC proliferation and activation. Preclinical studies also suggest several targets for the development of anti-fibrotic therapies; however, very few advanced to clinical trials. The pathophysiology of hepatic fibrosis is extremely complex and requires comprehensive understanding to identify effective therapeutic targets; therefore, in this review, we focus on the various cellular and molecular mechanisms associated with the pathophysiology of hepatic fibrosis and discuss potential strategies to control or reverse the fibrosis.<\/jats:p>","DOI":"10.3390\/cells10051097","type":"journal-article","created":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T11:06:01Z","timestamp":1620212761000},"page":"1097","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":128,"title":["Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured?"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6045-6884","authenticated-orcid":false,"given":"Arshi","family":"Khanam","sequence":"first","affiliation":[{"name":"Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul G.","family":"Saleeb","sequence":"additional","affiliation":[{"name":"Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7471-0812","authenticated-orcid":false,"given":"Shyam","family":"Kottilil","sequence":"additional","affiliation":[{"name":"Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,5,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jhep.2016.04.018","article-title":"Sinusoidal communication in liver fibrosis and regeneration","volume":"65","author":"Marrone","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Huang, E., Peng, N., Xiao, F., Hu, D., Wang, X., and Lu, L. (2020). The Roles of Immune Cells in the Pathogenesis of Fibrosis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21155203"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s40139-015-0077-z","article-title":"Key Fibrogenic Signaling","volume":"3","author":"He","year":"2015","journal-title":"Curr. Pathobiol. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"764641","DOI":"10.1155\/2015\/764641","article-title":"Fibrosis Related Inflammatory Mediators: Role of the IL-10 Cytokine Family","volume":"2015","author":"Sziksz","year":"2015","journal-title":"Mediators. Inflamm."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/hep.27332","article-title":"Hepatic inflammation and fibrosis: Functional links and key pathways","volume":"61","author":"Seki","year":"2015","journal-title":"Hepatology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bpg.2011.02.005","article-title":"Mechanisms of hepatic fibrogenesis","volume":"25","author":"Lee","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"574276","DOI":"10.3389\/fimmu.2020.574276","article-title":"Immunomodulatory Role of the Extracellular Matrix Within the Liver Disease Microenvironment","volume":"11","author":"McQuitty","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_9","first-page":"661","article-title":"Noninvasive Diagnosis of NASH and Liver Fibrosis Within the Spectrum of NAFLD","volume":"8","author":"Alkhouri","year":"2012","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"11118","DOI":"10.3748\/wjg.v21.i39.11118","article-title":"Hepatic differentiation of rat induced pluripotent stem cells in vitro","volume":"21","author":"Sun","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_11","first-page":"147","article-title":"Alcoholic Liver Disease: Pathogenesis and Current Management","volume":"38","author":"Osna","year":"2017","journal-title":"Alcohol Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1097\/MEG.0000000000001437","article-title":"Noninvasive inflammatory markers for assessing liver fibrosis stage in autoimmune hepatitis patients","volume":"31","author":"Yuan","year":"2019","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_13","first-page":"73","article-title":"Drug-induced Liver Injury","volume":"6","author":"David","year":"2010","journal-title":"US Gastroenterol. Hepatol. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.3892\/etm.2017.4422","article-title":"Chronic hepatitis B patients with high liver fibrosis levels should receive antiviral treatment","volume":"13","author":"Li","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/cld.904","article-title":"Development of Hepatocellular Carcinoma in Patients With Suppressed Viral Replication: Changes in Risk Over Time","volume":"15","author":"Udompap","year":"2020","journal-title":"Clin. Liver Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/hepr.12810","article-title":"Genetic prevention of hepatitis C virus-induced liver fibrosis by allele-specific downregulation of MERTK","volume":"47","author":"Cavalli","year":"2017","journal-title":"Hepatol. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"G697","DOI":"10.1152\/ajpgi.00426.2010","article-title":"Obesity, diabetes mellitus, and liver fibrosis","volume":"300","author":"Chiang","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0016-5085(00)70364-7","article-title":"Liver fibrosis in overweight patients","volume":"118","author":"Ratziu","year":"2000","journal-title":"Gastroenterology"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Baiocchini, A., Montaldo, C., Conigliaro, A., Grimaldi, A., Correani, V., Mura, F., Ciccosanti, F., Rotiroti, N., Brenna, A., and Montalbano, M. (2016). Extracellular Matrix Molecular Remodeling in Human Liver Fibrosis Evolution. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0151736"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.3748\/wjg.v22.i4.1348","article-title":"Hepatic non-parenchymal cells: Master regulators of alcoholic liver disease?","volume":"22","author":"Seo","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/hep.20051","article-title":"Apoptosis: The nexus of liver injury and fibrosis","volume":"39","author":"Canbay","year":"2004","journal-title":"Hepatology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/cphy.c120026","article-title":"Kupffer cells in the liver","volume":"3","author":"Dixon","year":"2013","journal-title":"Compr. Physiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.3389\/fimmu.2019.02852","article-title":"Therapeutic Targeting of Hepatic Macrophages for the Treatment of Liver Diseases","volume":"10","author":"Weiskirchen","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"7879","DOI":"10.3892\/mmr.2017.7641","article-title":"PDGF signaling pathway in hepatic fibrosis pathogenesis and therapeutics (Review)","volume":"16","author":"Ying","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Dewidar, B., Meyer, C., Dooley, S., and Meindl-Beinker, A.N. (2019). TGF-beta in Hepatic Stellate Cell Activation and Liver Fibrogenesis-Updated 2019. Cells, 8.","DOI":"10.3390\/cells8111419"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1038\/s41598-019-39112-6","article-title":"Transcriptional regulation of Hepatic Stellate Cell activation in NASH","volume":"9","author":"Marcher","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cld.2008.07.002","article-title":"Immune interactions in hepatic fibrosis","volume":"12","author":"Holt","year":"2008","journal-title":"Clin. Liver Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/cmi.2016.3","article-title":"Liver immunology and its role in inflammation and homeostasis","volume":"13","author":"Robinson","year":"2016","journal-title":"Cell Mol. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3748\/wjg.v26.i2.109","article-title":"Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C","volume":"26","author":"Tanwar","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.cld.2008.07.008","article-title":"Cellular sources of extracellular matrix in hepatic fibrosis","volume":"12","author":"Wells","year":"2008","journal-title":"Clin. Liver Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"a021428","DOI":"10.1101\/cshperspect.a021428","article-title":"Immune Response in Hepatitis B Virus Infection","volume":"5","author":"Tan","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.3389\/fimmu.2018.02201","article-title":"Inflammasome: A Double-Edged Sword in Liver Diseases","volume":"9","author":"Luan","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"7269150","DOI":"10.1155\/2020\/7269150","article-title":"The Role of Autophagy and NLRP3 Inflammasome in Liver Fibrosis","volume":"2020","author":"Tao","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/hep.30252","article-title":"NLR Family Pyrin Domain-Containing 3 Inflammasome Activation in Hepatic Stellate Cells Induces Liver Fibrosis in Mice","volume":"69","author":"Inzaugarat","year":"2019","journal-title":"Hepatology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/hep.26592","article-title":"NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice","volume":"59","author":"Wree","year":"2014","journal-title":"Hepatology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/cld.702","article-title":"Hepatic fibrosis: Avenues of investigation and clinical implications","volume":"11","author":"Shay","year":"2018","journal-title":"Clin. Liver Dis."},{"key":"ref_37","first-page":"5363","article-title":"Predictors for advanced liver fibrosis in chronic hepatitis B virus infection with persistently normal or mildly elevated alanine aminotransferase","volume":"14","author":"Wang","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"6663","DOI":"10.3748\/wjg.v22.i29.6663","article-title":"Noninvasive models for assessment of liver fibrosis in patients with chronic hepatitis B virus infection","volume":"22","author":"Zeng","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mam.2007.10.001","article-title":"Alcohol induced hepatic fibrosis: Role of acetaldehyde","volume":"29","author":"Mello","year":"2008","journal-title":"Mol. Aspects Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1530-0277.2010.01422.x","article-title":"Leptin and acetaldehyde synergistically promotes alphaSMA expression in hepatic stellate cells by an interleukin 6-dependent mechanism","volume":"35","author":"Liu","year":"2011","journal-title":"Alcohol Clin. Exp. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/j.1440-1746.2011.06756.x","article-title":"Pathogenesis of alcohol-induced liver disease: Classical concepts and recent advances","volume":"26","author":"Seth","year":"2011","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.3748\/wjg.v17.i20.2543","article-title":"Hepatic stellate cells and innate immunity in alcoholic liver disease","volume":"17","author":"Suh","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"G516","DOI":"10.1152\/ajpgi.00537.2010","article-title":"Innate immunity in alcoholic liver disease","volume":"300","author":"Gao","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/hep.23739","article-title":"Endothelial cell toll-like receptor 4 regulates fibrosis-associated angiogenesis in the liver","volume":"52","author":"Jagavelu","year":"2010","journal-title":"Hepatology"},{"key":"ref_45","first-page":"265","article-title":"NASH: The Hepatic injury of Metabolic syndrome: A brief update","volume":"3","author":"M","year":"2009","journal-title":"Int. J. Health Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1089\/ars.2008.2142","article-title":"Oxidative stress in the regulation of normal and neoplastic hematopoiesis","volume":"10","author":"Ghaffari","year":"2008","journal-title":"Antioxid. Redox. Signal."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Sircana, A., Paschetta, E., Saba, F., Molinaro, F., and Musso, G. (2019). Recent Insight into the Role of Fibrosis in Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20071745"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4103\/sjg.SJG_297_17","article-title":"Involvement of epithelial-mesenchymal transition in liver fibrosis","volume":"24","author":"Yu","year":"2018","journal-title":"Saudi J. Gastroenterol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.4254\/wjh.v8.i28.1157","article-title":"Cirrhosis and autoimmune liver disease: Current understanding","volume":"8","author":"Liberal","year":"2016","journal-title":"World J. Hepatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/hep.29289","article-title":"Linking long noncoding RNA to control bile acid signaling and cholestatic liver fibrosis","volume":"66","author":"Chiang","year":"2017","journal-title":"Hepatology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1017\/S1462399409000994","article-title":"Cholangiocyte proliferation and liver fibrosis","volume":"11","author":"Glaser","year":"2009","journal-title":"Expert Rev. Mol. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"158547","DOI":"10.1155\/2012\/158547","article-title":"Cell signals influencing hepatic fibrosis","volume":"2012","author":"Cong","year":"2012","journal-title":"Int. J. Hepatol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1089\/ars.2013.5697","article-title":"Extracellular matrix and liver disease","volume":"21","author":"Arriazu","year":"2014","journal-title":"Antioxid. Redox. Signal."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol. Rev."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/01.LAB.0000069036.63405.5C","article-title":"Apoptotic body engulfment by a human stellate cell line is profibrogenic","volume":"83","author":"Canbay","year":"2003","journal-title":"Lab. Investig."},{"key":"ref_57","first-page":"1","article-title":"Oxidative Stress and Hepatic Stellate Cells: A Paradoxical Relationship","volume":"7","author":"Gandhi","year":"2012","journal-title":"Trends Cell Mol. Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1053\/gast.2003.50012","article-title":"Liver fibrosis: Insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors","volume":"124","author":"Yang","year":"2003","journal-title":"Gastroenterology"},{"key":"ref_59","first-page":"344","article-title":"Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology","volume":"3","author":"Weiskirchen","year":"2014","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Nagaraja, T., Chen, L., Balasubramanian, A., Groopman, J.E., Ghoshal, K., Jacob, S.T., Leask, A., Brigstock, D.R., Anand, A.R., and Ganju, R.K. (2012). Activation of the connective tissue growth factor (CTGF)-transforming growth factor beta 1 (TGF-beta 1) axis in hepatitis C virus-expressing hepatocytes. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0046526"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/emm.2005.19","article-title":"HCV core protein promotes liver fibrogenesis via up-regulation of CTGF with TGF-beta1","volume":"37","author":"Shin","year":"2005","journal-title":"Exp. Mol. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrgastro.2010.213","article-title":"NF-kappaB in the liver--linking injury, fibrosis and hepatocellular carcinoma","volume":"8","author":"Luedde","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0002-9440(10)63544-4","article-title":"Hepatocytes express nerve growth factor during liver injury: Evidence for paracrine regulation of hepatic stellate cell apoptosis","volume":"163","author":"Oakley","year":"2003","journal-title":"Am. J. Pathol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.3748\/wjg.v13.i22.3056","article-title":"Transforming growth factor-beta and fibrosis","volume":"13","author":"Verrecchia","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1369\/0022155415627681","article-title":"TGF-beta\/SMAD Pathway and Its Regulation in Hepatic Fibrosis","volume":"64","author":"Xu","year":"2016","journal-title":"J. Histochem. Cytochem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1055\/s-0037-1617455","article-title":"Liver Sinusoidal Endothelial Cell: An Update","volume":"37","author":"DeLeve","year":"2017","journal-title":"Semin. Liver Dis."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41575-018-0020-y","article-title":"Liver sinusoidal endothelial cells - gatekeepers of hepatic immunity","volume":"15","author":"Shetty","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0002-9440(10)63487-6","article-title":"Capillarization of hepatic sinusoid by liver endothelial cell-reactive autoantibodies in patients with cirrhosis and chronic hepatitis","volume":"163","author":"Xu","year":"2003","journal-title":"Am. J. Pathol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/labinvest.2015.95","article-title":"Pivotal role of liver sinusoidal endothelial cells in NAFLD\/NASH progression","volume":"95","author":"Miyao","year":"2015","journal-title":"Lab. Investig."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/hep.22351","article-title":"Sinusoidal endothelial cells prevent rat stellate cell activation and promote reversion to quiescence","volume":"48","author":"Deleve","year":"2008","journal-title":"Hepatology"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jcmgh.2015.06.011","article-title":"Angiogenesis and Fibrogenesis in Chronic Liver Diseases","volume":"1","author":"Bocca","year":"2015","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nature12681","article-title":"Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis","volume":"505","author":"Ding","year":"2014","journal-title":"Nature"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.3748\/wjg.v12.i46.7413","article-title":"Role of Kupffer cells in the pathogenesis of liver disease","volume":"12","author":"Kolios","year":"2006","journal-title":"World J. Gastroenterol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.molimm.2017.02.018","article-title":"The role of Kupffer cells in hepatic diseases","volume":"85","author":"Li","year":"2017","journal-title":"Mol. Immunol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1038\/labinvest.2010.123","article-title":"Kupffer cells are associated with apoptosis, inflammation and fibrotic effects in hepatic fibrosis in rats","volume":"90","author":"Liu","year":"2010","journal-title":"Lab. Investig."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jhep.2013.12.025","article-title":"Macrophage heterogeneity in liver injury and fibrosis","volume":"60","author":"Tacke","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.3389\/fimmu.2020.01193","article-title":"Effect of Hepatic Macrophage Polarization and Apoptosis on Liver Ischemia and Reperfusion Injury During Liver Transplantation","volume":"11","author":"Ye","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/hep4.1356","article-title":"Liver Macrophages: Old Dogmas and New Insights","volume":"3","author":"Guillot","year":"2019","journal-title":"Hepatol. Commun."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3389\/fonc.2018.00357","article-title":"Transforming Growth Factor-beta-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis","volume":"8","author":"Fabregat","year":"2018","journal-title":"Front. Oncol."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Kany, S., Vollrath, J.T., and Relja, B. (2019). Cytokines in Inflammatory Disease. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20236008"},{"key":"ref_81","first-page":"101","article-title":"Kupffer Cell Metabolism and Function","volume":"1","author":"Horuzsko","year":"2015","journal-title":"J. Enzymol. Metab."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1172\/JCI88881","article-title":"Liver inflammation and fibrosis","volume":"127","author":"Koyama","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrgastro.2015.200","article-title":"Immunology in the liver--from homeostasis to disease","volume":"13","author":"Heymann","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","article-title":"Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues","volume":"65","author":"Parola","year":"2019","journal-title":"Mol. Aspects Med."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Geervliet, E., and Bansal, R. (2020). Matrix Metalloproteinases as Potential Biomarkers and Therapeutic Targets in Liver Diseases. Cells, 9.","DOI":"10.3390\/cells9051212"},{"key":"ref_86","first-page":"364","article-title":"Therapeutic targeting of liver inflammation and fibrosis by nanomedicine","volume":"3","author":"Bartneck","year":"2014","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"ref_87","first-page":"323","article-title":"Elevated Expression of Chemokine CXCL13 in Chronic Hepatitis B Patients Links to Immune Control during Antiviral Therapy","volume":"8","author":"Liu","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_88","first-page":"103","article-title":"Margatoxin mitigates CCl4induced hepatic fibrosis in mice via macrophage polarization, cytokine secretion and STAT signaling","volume":"45","author":"Wu","year":"2020","journal-title":"Int. J. Mol. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e12731","DOI":"10.1111\/cpr.12731","article-title":"TIM-4 interference in Kupffer cells against CCL4-induced liver fibrosis by mediating Akt1\/Mitophagy signalling pathway","volume":"53","author":"Wu","year":"2020","journal-title":"Cell Prolif."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1002\/hep.27334","article-title":"T-cell immunoglobulin and mucin domain 4 (TIM-4) signaling in innate immune-mediated liver ischemia-reperfusion injury","volume":"60","author":"Ji","year":"2014","journal-title":"Hepatology"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"5178","DOI":"10.1096\/fj.201902307RRR","article-title":"Exosomal miR-103-3p from LPS-activated THP-1 macrophage contributes to the activation of hepatic stellate cells","volume":"34","author":"Chen","year":"2020","journal-title":"FASEB J."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e88689","DOI":"10.1172\/jci.insight.88689","article-title":"IRF5 governs liver macrophage activation that promotes hepatic fibrosis in mice and humans","volume":"1","author":"Alzaid","year":"2016","journal-title":"JCI Insight."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"9466","DOI":"10.1096\/fj.201900215RR","article-title":"TG101348, a selective JAK2 antagonist, ameliorates hepatic fibrogenesis in vivo","volume":"33","author":"Akcora","year":"2019","journal-title":"FASEB J."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fphys.2012.00069","article-title":"Cytokines and STATs in Liver Fibrosis","volume":"3","author":"Kong","year":"2012","journal-title":"Front. Physiol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.3389\/fimmu.2019.01582","article-title":"The Roles of Liver-Resident Lymphocytes in Liver Diseases","volume":"10","author":"Wang","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.jhep.2011.04.030","article-title":"NKT cells in liver fibrosis: Controversies or complexities","volume":"55","author":"Wang","year":"2011","journal-title":"J. Hepatol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.3389\/fimmu.2018.02082","article-title":"Complex Network of NKT Cell Subsets Controls Immune Homeostasis in Liver and Gut","volume":"9","author":"Marrero","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/hep.23599","article-title":"Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease","volume":"51","author":"Syn","year":"2010","journal-title":"Hepatology"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.aohep.2018.12.001","article-title":"Group 2 innate lymphoid cells exhibit progressively higher levels of activation during worsening of liver fibrosis","volume":"18","author":"Cervera","year":"2019","journal-title":"Ann. Hepatol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.immuni.2013.07.018","article-title":"Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis","volume":"39","author":"McHedlidze","year":"2013","journal-title":"Immunity"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/cmi.2016.62","article-title":"Interleukin-33 in the pathogenesis of liver fibrosis: Alarming ILC2 and hepatic stellate cells","volume":"14","author":"Weiskirchen","year":"2017","journal-title":"Cell Mol. Immunol."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Ochel, A., Tiegs, G., and Neumann, K. (2019). Type 2 Innate Lymphoid Cells in Liver and Gut: From Current Knowledge to Future Perspectives. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20081896"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/JID.2015.406","article-title":"IL-33-Dependent Group 2 Innate Lymphoid Cells Promote Cutaneous Wound Healing","volume":"136","author":"Rak","year":"2016","journal-title":"J. Investig. Dermatol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jhep.2011.03.022","article-title":"Protective role of IL-33\/ST2 axis in Con A-induced hepatitis","volume":"56","author":"Volarevic","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.immuni.2007.07.023","article-title":"Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation","volume":"27","author":"Zenewicz","year":"2007","journal-title":"Immunity"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3389\/fimmu.2017.01195","article-title":"Immunity and Fibrogenesis: The Role of Th17\/IL-17 Axis in HBV and HCV-induced Chronic Hepatitis and Progression to Cirrhosis","volume":"8","author":"Paquissi","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"9922","DOI":"10.18632\/oncotarget.14266","article-title":"Antagonism of Interleukin-17A ameliorates experimental hepatic fibrosis by restoring the IL-10\/STAT3-suppressed autophagy in hepatocytes","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3389\/fimmu.2019.00477","article-title":"gammadeltaT Cells Suppress Liver Fibrosis via Strong Cytolysis and Enhanced NK Cell-Mediated Cytotoxicity against Hepatic Stellate Cells","volume":"10","author":"Liu","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1053\/j.gastro.2012.05.049","article-title":"Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice","volume":"143","author":"Meng","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/hep.23148","article-title":"Immature myeloid cells induced by a high-fat diet contribute to liver inflammation","volume":"50","author":"Deng","year":"2009","journal-title":"Hepatology"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jhep.2015.07.030","article-title":"Hepatocyte exosomes mediate liver repair and regeneration via sphingosine-1-phosphate","volume":"64","author":"Nojima","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"8530","DOI":"10.1096\/fj.201802675R","article-title":"Exosomes from activated hepatic stellate cells contain GLUT1 and PKM2: A role for exosomes in metabolic switch of liver nonparenchymal cells","volume":"33","author":"Wan","year":"2019","journal-title":"FASEB J."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/hep.28644","article-title":"Exosome-mediated activation of toll-like receptor 3 in stellate cells stimulates interleukin-17 production by gammadelta T cells in liver fibrosis","volume":"64","author":"Seo","year":"2016","journal-title":"Hepatology"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1038\/s41598-017-03389-2","article-title":"Exosomes derived from palmitic acid-treated hepatocytes induce fibrotic activation of hepatic stellate cells","volume":"7","author":"Lee","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1089\/scd.2012.0395","article-title":"Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis","volume":"22","author":"Li","year":"2013","journal-title":"Stem Cells Dev."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1016\/j.ajpath.2016.07.011","article-title":"Fibrogenic Signaling Is Suppressed in Hepatic Stellate Cells through Targeting of Connective Tissue Growth Factor (CCN2) by Cellular or Exosomal MicroRNA-199a-5p","volume":"186","author":"Chen","year":"2016","journal-title":"Am. J. Pathol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1053\/j.gastro.2014.10.040","article-title":"Hepatitis C virus infection induces autocrine interferon signaling by human liver endothelial cells and release of exosomes, which inhibits viral replication","volume":"148","author":"Giugliano","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2567.2004.01959.x","article-title":"The macrophage and the apoptotic cell: An innate immune interaction viewed simplistically?","volume":"113","author":"Gregory","year":"2004","journal-title":"Immunology"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1053\/jhep.2003.50472","article-title":"Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression","volume":"38","author":"Canbay","year":"2003","journal-title":"Hepatology"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1053\/gast.2002.35953","article-title":"Fas enhances fibrogenesis in the bile duct ligated mouse: A link between apoptosis and fibrosis","volume":"123","author":"Canbay","year":"2002","journal-title":"Gastroenterology"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1172\/JCI200317740","article-title":"Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis","volume":"112","author":"Canbay","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1053\/j.gastro.2004.07.019","article-title":"Hepatocyte-specific disruption of Bcl-xL leads to continuous hepatocyte apoptosis and liver fibrotic responses","volume":"127","author":"Takehara","year":"2004","journal-title":"Gastroenterology"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1038\/s41467-020-16241-5","article-title":"Immune modulation by complement receptor 3-dependent human monocyte TGF-beta1-transporting vesicles","volume":"11","author":"Halder","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/hep.21093","article-title":"Phagocytosis of apoptotic bodies by hepatic stellate cells induces NADPH oxidase and is associated with liver fibrosis in vivo","volume":"43","author":"Zhan","year":"2006","journal-title":"Hepatology"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41421-020-0167-x","article-title":"Inflammasome activation and regulation: Toward a better understanding of complex mechanisms","volume":"6","author":"Zheng","year":"2020","journal-title":"Cell Discov."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","article-title":"NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice","volume":"66","author":"Mridha","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13071-018-3223-8","article-title":"NLRP3 inflammasome activation from Kupffer cells is involved in liver fibrosis of Schistosoma japonicum-infected mice via NF-kappaB","volume":"12","author":"Zhang","year":"2019","journal-title":"Parasit Vectors"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1177\/0960327120961158","article-title":"The cross-talk of NLRP3 inflammasome activation and necroptotic hepatocyte death in acetaminophen-induced mice acute liver injury","volume":"40","author":"Li","year":"2021","journal-title":"Hum. Exp. Toxicol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.14336\/AD.2019.0116","article-title":"Pyroptosis in Liver Disease: New Insights into Disease Mechanisms","volume":"10","author":"Wu","year":"2019","journal-title":"Aging Dis."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"6489012","DOI":"10.1155\/2016\/6489012","article-title":"Role of NLRP3 Inflammasome in the Progression of NAFLD to NASH","volume":"2016","author":"Wan","year":"2016","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nri3452","article-title":"Activation and regulation of the inflammasomes","volume":"13","author":"Latz","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Dixon, L.J., Flask, C.A., Papouchado, B.G., Feldstein, A.E., and Nagy, L.E. (2013). Caspase-1 as a central regulator of high fat diet-induced non-alcoholic steatohepatitis. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0056100"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.3389\/fimmu.2017.01728","article-title":"Relevance of the NLRP3 Inflammasome in the Pathogenesis of Chronic Liver Disease","volume":"8","author":"Wu","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Lan, T., Kisseleva, T., and Brenner, D.A. (2015). Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0129743"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/s41419-018-0752-1","article-title":"MicroRNA-214 promotes hepatic stellate cell activation and liver fibrosis by suppressing Sufu expression","volume":"9","author":"Ma","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1111\/j.1742-4658.2010.07632.x","article-title":"MicroRNAs and the regulation of fibrosis","volume":"277","author":"Jiang","year":"2010","journal-title":"FEBS J."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13578-017-0161-7","article-title":"The roles of microRNA families in hepatic fibrosis","volume":"7","author":"Jiang","year":"2017","journal-title":"Cell Biosci."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1007\/s00705-015-2474-3","article-title":"Increased miR-16 expression induced by hepatitis C virus infection promotes liver fibrosis through downregulation of hepatocyte growth factor and Smad7","volume":"160","author":"Zhu","year":"2015","journal-title":"Arch. Virol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10735-013-9532-5","article-title":"Potential role of Hedgehog signaling and microRNA-29 in liver fibrosis of IKKbeta-deficient mouse","volume":"45","author":"Hyun","year":"2014","journal-title":"J. Mol. Histol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1016\/j.ajpath.2017.08.027","article-title":"Regulation of Cellular Senescence by miR-34a in Alcoholic Liver Injury","volume":"187","author":"Wan","year":"2017","journal-title":"Am. J. Pathol."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Tian, X.F., Ji, F.J., Zang, H.L., and Cao, H. (2016). Activation of the miR-34a\/SIRT1\/p53 Signaling Pathway Contributes to the Progress of Liver Fibrosis via Inducing Apoptosis in Hepatocytes but Not in HSCs. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0158657"},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Zhao, J., Tang, N., Wu, K., Dai, W., Ye, C., Shi, J., Zhang, J., Ning, B., Zeng, X., and Lin, Y. (2014). MiR-21 simultaneously regulates ERK1 signaling in HSC activation and hepatocyte EMT in hepatic fibrosis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0108005"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41420-018-0076-z","article-title":"Modulation of liver steatosis by miR-21\/PPARalpha","volume":"4","author":"Rodrigues","year":"2018","journal-title":"Cell Death Discov."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1111\/j.1582-4934.2012.01578.x","article-title":"Hepatic miR-29ab1 expression modulates chronic hepatic injury","volume":"16","author":"Kogure","year":"2012","journal-title":"J. Cell Mol. Med."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fmed.2020.00007","article-title":"Critical Role of microRNA-21 in the Pathogenesis of Liver Diseases","volume":"7","author":"Zhang","year":"2020","journal-title":"Front. Med."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"G539","DOI":"10.1152\/ajpgi.00249.2018","article-title":"lncRNA GAS5 restrains CCl4-induced hepatic fibrosis by targeting miR-23a through the PTEN\/PI3K\/Akt signaling pathway","volume":"316","author":"Dong","year":"2019","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_147","first-page":"3190","article-title":"High glucose promotes hepatic fibrosis via miR32\/MTA3mediated epithelialtomesenchymal transition","volume":"19","author":"Li","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ajpath.2012.06.010","article-title":"Epigenetic regulation of miR-34a expression in alcoholic liver injury","volume":"181","author":"Meng","year":"2012","journal-title":"Am. J. Pathol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11010-014-2199-8","article-title":"Hepatic stellate cell is activated by microRNA-181b via PTEN\/Akt pathway","volume":"398","author":"Zheng","year":"2015","journal-title":"Mol. Cell Biochem."},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Gupta, P., Sata, T.N., Yadav, A.K., Mishra, A., Vats, N., Hossain, M.M., Sanal, M.G., and Venugopal, S.K. (2019). TGF-beta induces liver fibrosis via miRNA-181a-mediated down regulation of augmenter of liver regeneration in hepatic stellate cells. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0214534"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"4468","DOI":"10.3748\/wjg.v25.i31.4468","article-title":"MicroRNA-194 inactivates hepatic stellate cells and alleviates liver fibrosis by inhibiting AKT2","volume":"25","author":"Wu","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"G101","DOI":"10.1152\/ajpgi.00220.2009","article-title":"Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation","volume":"298","author":"Venugopal","year":"2010","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Murakami, Y., Toyoda, H., Tanaka, M., Kuroda, M., Harada, Y., Matsuda, F., Tajima, A., Kosaka, N., Ochiya, T., and Shimotohno, K. (2011). The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0016081"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/cas.12730","article-title":"Inhibition of microRNA-214 ameliorates hepatic fibrosis and tumor incidence in platelet-derived growth factor C transgenic mice","volume":"106","author":"Okada","year":"2015","journal-title":"Cancer Sci."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1755-1536-5-12","article-title":"Induction of microRNA-214-5p in human and rodent liver fibrosis","volume":"5","author":"Iizuka","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.18632\/aging.102705","article-title":"Hsa_circ_0070963 inhibits liver fibrosis via regulation of miR-223-3p and LEMD3","volume":"12","author":"Ji","year":"2020","journal-title":"Aging"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s10020-020-00207-w","article-title":"Exosomal miR-223 derived from natural killer cells inhibits hepatic stellate cell activation by suppressing autophagy","volume":"26","author":"Wang","year":"2020","journal-title":"Mol. Med."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jhep.2018.08.026","article-title":"MicroRNA-378 promotes hepatic inflammation and fibrosis via modulation of the NF-kappaB-TNFalpha pathway","volume":"70","author":"Zhang","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"10993","DOI":"10.1038\/ncomms10993","article-title":"MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression","volume":"7","author":"Hyun","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1002\/jcb.27746","article-title":"MiR-542-3p controls hepatic stellate cell activation and fibrosis via targeting BMP-7","volume":"120","author":"Ji","year":"2019","journal-title":"J. Cell Biochem."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"173507","DOI":"10.1016\/j.ejphar.2020.173507","article-title":"MicroRNA interplay between hepatic stellate cell quiescence and activation","volume":"885","author":"Ezhilarasan","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/liv.12395","article-title":"Regression of fibrosis after HBV antiviral therapy. Is cirrhosis reversible?","volume":"34 Suppl 1","author":"Calvaruso","year":"2014","journal-title":"Liver Int."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"6304","DOI":"10.3748\/wjg.v26.i41.6304","article-title":"Efficacy and safety of anti-hepatic fibrosis drugs","volume":"26","author":"Damiris","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/s10620-014-3380-3","article-title":"Total body weight loss of >\/= 10% is associated with improved hepatic fibrosis in patients with nonalcoholic steatohepatitis","volume":"60","author":"Glass","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Yamada, K., Mizukoshi, E., Seike, T., Horii, R., Kitahara, M., Sunagozaka, H., Arai, K., Yamashita, T., Honda, M., and Kaneko, S. (2018). Light alcohol consumption has the potential to suppress hepatocellular injury and liver fibrosis in non-alcoholic fatty liver disease. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0191026"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.3748\/wjg.v20.i10.2515","article-title":"Hepatic inflammation and progressive liver fibrosis in chronic liver disease","volume":"20","author":"Czaja","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.jcmgh.2021.01.012","article-title":"Transcriptional Regulation of Metabolic Pathways via Lipid-Sensing Nuclear Receptors PPARs, FXR, and LXR in NASH","volume":"11","author":"Cariello","year":"2021","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Li, J., Kuruba, R., Wilson, A., Gao, X., Zhang, Y., and Li, S. (2010). Inhibition of endothelin-1-mediated contraction of hepatic stellate cells by FXR ligand. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0013955"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/S0140-6736(19)33041-7","article-title":"Obeticholic acid for the treatment of non-alcoholic steatohepatitis: Interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial","volume":"394","author":"Younossi","year":"2019","journal-title":"Lancet"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"6970407","DOI":"10.1155\/2018\/6970407","article-title":"PPARgamma Antagonizes Hypoxia-Induced Activation of Hepatic Stellate Cell through Cross Mediating PI3K\/AKT and cGMP\/PKG Signaling","volume":"2018","author":"Zhang","year":"2018","journal-title":"PPAR Res."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"106170","DOI":"10.1016\/j.cct.2020.106170","article-title":"A randomised, double-blind, placebo-controlled, multi-centre, dose-range, proof-of-concept, 24-week treatment study of lanifibranor in adult subjects with non-alcoholic steatohepatitis: Design of the NATIVE study","volume":"98","author":"Sven","year":"2020","journal-title":"Contemp. Clin. Trials."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"6997","DOI":"10.2147\/IJN.S145951","article-title":"Nanoparticles for the treatment of liver fibrosis","volume":"12","author":"Moon","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nrd4333","article-title":"Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery","volume":"13","author":"Torchilin","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"23996","DOI":"10.1074\/jbc.M311668200","article-title":"Engagement of alphavbeta3 integrin regulates proliferation and apoptosis of hepatic stellate cells","volume":"279","author":"Zhou","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00795-003-0230-3","article-title":"Structure and function of hepatic stellate cells","volume":"37","author":"Senoo","year":"2004","journal-title":"Med. Electron. Microsc."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/01.LAB.0000054178.01162.E4","article-title":"The myofibroblastic conversion of peribiliary fibrogenic cells distinct from hepatic stellate cells is stimulated by platelet-derived growth factor during liver fibrogenesis","volume":"83","author":"Kinnman","year":"2003","journal-title":"Lab. Investig."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1002\/hep.22890","article-title":"Hepatic stellate cells express functional CXCR4: Role in stromal cell-derived factor-1alpha-mediated stellate cell activation","volume":"49","author":"Hong","year":"2009","journal-title":"Hepatology"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"15398","DOI":"10.1074\/jbc.M414048200","article-title":"Role of CD44 in epithelial wound repair: Migration of rat hepatic stellate cells utilizes hyaluronic acid and CD44v6","volume":"280","author":"Kikuchi","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.2147\/IJN.S171280","article-title":"CXCR4-targeted liposomal mediated co-delivery of pirfenidone and AMD3100 for the treatment of TGFbeta-induced HSC-T6 cells activation","volume":"14","author":"Ullah","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Chen, Y.N., Hsu, S.L., Liao, M.Y., Liu, Y.T., Lai, C.H., Chen, J.F., Nguyen, M.T., Su, Y.H., Chen, S.T., and Wu, L.C. (2016). Ameliorative Effect of Curcumin-Encapsulated Hyaluronic Acid-PLA Nanoparticles on Thioacetamide-Induced Murine Hepatic Fibrosis. Int. J. Environ. Res. Public Health, 14.","DOI":"10.3390\/ijerph14010011"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nbt1396","article-title":"Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone","volume":"26","author":"Sato","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"222","DOI":"10.14218\/JCTH.2020.00026","article-title":"Hepatic Antifibrotic Pharmacotherapy: Are We Approaching Success?","volume":"8","author":"Chang","year":"2020","journal-title":"J. Clin. Transl Hepatol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"7629724","DOI":"10.1155\/2016\/7629724","article-title":"Clinical Advancements in the Targeted Therapies against Liver Fibrosis","volume":"2016","author":"Bansal","year":"2016","journal-title":"Mediators. Inflamm."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1440-1746.2006.04756.x","article-title":"Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis","volume":"22","author":"Satapathy","year":"2007","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s12325-017-0547-2","article-title":"Repurposing Pentoxifylline for the Treatment of Fibrosis: An Overview","volume":"34","author":"Wen","year":"2017","journal-title":"Adv. Ther."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.3748\/wjg.v23.i19.3396","article-title":"Renin angiotensin system in liver diseases: Friend or foe?","volume":"23","author":"Simoes","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3904\/kjim.2017.317","article-title":"Role of the renin-angiotensin system in hepatic fibrosis and portal hypertension","volume":"33","author":"Shim","year":"2018","journal-title":"Korean J. Intern. Med."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00029330-200801020-00013","article-title":"Effect of angiotensin II and angiotensin II type 1 receptor antagonist on the proliferation, contraction and collagen synthesis in rat hepatic stellate cells","volume":"121","author":"Liu","year":"2008","journal-title":"Chin. Med. J."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0016-5085(00)70368-4","article-title":"Angiotensin II induces contraction and proliferation of human hepatic stellate cells","volume":"118","author":"Bataller","year":"2000","journal-title":"Gastroenterology"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"249","DOI":"10.21037\/hbsn.2016.02.06","article-title":"Losartan may inhibit the progression of liver fibrosis in chronic HCV patients","volume":"5","author":"Salama","year":"2016","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0140-6736(12)61425-1","article-title":"Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: A 5-year open-label follow-up study","volume":"381","author":"Marcellin","year":"2013","journal-title":"Lancet"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/10\/5\/1097\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:57:03Z","timestamp":1760162223000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/10\/5\/1097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,4]]},"references-count":191,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,5]]}},"alternative-id":["cells10051097"],"URL":"https:\/\/doi.org\/10.3390\/cells10051097","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,4]]}}}